These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24472060)

  • 1. Opportunities for improving therapy development in ALS.
    Bruijn L; Cudkowicz M;
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Jun; 15(3-4):169-73. PubMed ID: 24472060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward more efficient clinical trials for amyotrophic lateral sclerosis.
    Cudkowicz ME; Katz J; Moore DH; O'Neill G; Glass JD; Mitsumoto H; Appel S; Ravina B; Kieburtz K; Shoulson I; Kaufmann P; Khan J; Simpson E; Shefner J; Levin B; Cwik V; Schoenfeld D; Aggarwal S; McDermott MP; Miller RG
    Amyotroph Lateral Scler; 2010 May; 11(3):259-65. PubMed ID: 19961263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of phase II ALS clinical trials.
    Schoenfeld DA; Cudkowicz M
    Amyotroph Lateral Scler; 2008; 9(1):16-23. PubMed ID: 18273715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting success: optimizing phase II ALS trials for the transition to phase III.
    Berry JD; Cudkowicz ME; Shefner JM
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Mar; 15(1-2):1-8. PubMed ID: 24588460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental trials in amyotrophic lateral sclerosis: a review of recently completed, ongoing and planned trials using existing and novel drugs.
    Goyal NA; Mozaffar T
    Expert Opin Investig Drugs; 2014 Nov; 23(11):1541-51. PubMed ID: 24965719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infrastructure resources for clinical research in amyotrophic lateral sclerosis.
    Sherman AV; Gubitz AK; Al-Chalabi A; Bedlack R; Berry J; Conwit R; Harris BT; Horton DK; Kaufmann P; Leitner ML; Miller R; Shefner J; Vonsattel JP; Mitsumoto H
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 May; 14 Suppl 1():53-61. PubMed ID: 23678880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials?
    Atassi N; Beghi E; Blanquer M; Boulis NM; Cantello R; Caponnetto C; Chiò A; Dunnett SB; Feldman EL; Vescovi A; Mazzini L;
    Cytotherapy; 2016 Dec; 18(12):1471-1475. PubMed ID: 27720637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An efficient multi-stage, single-arm Phase II futility design for ALS.
    Palesch YY; Tilley BC
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():55-6. PubMed ID: 15512874
    [No Abstract]   [Full Text] [Related]  

  • 9. Palliative care in amyotrophic lateral sclerosis clinics: A survey of NEALS consortium membership.
    Mehta TR; Bayat E; Govindarajan R
    Muscle Nerve; 2021 May; 63(5):769-774. PubMed ID: 33580524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial.
    Leigh PN; Swash M; Iwasaki Y; Ludolph A; Meininger V; Miller RG; Mitsumoto H; Shaw P; Tashiro K; Van Den Berg L
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Jun; 5(2):84-98. PubMed ID: 15204010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Combined Assessment of Function and Survival (CAFS): a new endpoint for ALS clinical trials.
    Berry JD; Miller R; Moore DH; Cudkowicz ME; van den Berg LH; Kerr DA; Dong Y; Ingersoll EW; Archibald D
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Apr; 14(3):162-8. PubMed ID: 23323713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALS clinical research learning institutes (ALS-CRLI): empowering people with ALS to be research ambassadors.
    Bedlack R; Pogemiller A; Shefner J; Cudkowicz M; Heiman-Patterson T
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 May; 21(3-4):216-221. PubMed ID: 32458763
    [No Abstract]   [Full Text] [Related]  

  • 13. New therapy options for amyotrophic lateral sclerosis.
    Gordon P; Corcia P; Meininger V
    Expert Opin Pharmacother; 2013 Oct; 14(14):1907-17. PubMed ID: 23855817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Update on fundamental and clinical research in amyotrophic lateral sclerosis].
    Pradat PF; Camdessanché JP; Carluer L; Cintas P; Corcia P; Danel-Brunaud V; Echaniz-Laguna A; Gonzalez J; Nicolas G; Vandenberghe N; Verschueren A;
    Rev Neurol (Paris); 2009; 165(6-7):532-41. PubMed ID: 19419744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of biomarkers in ALS drug development and clinical trials.
    Bakkar N; Boehringer A; Bowser R
    Brain Res; 2015 May; 1607():94-107. PubMed ID: 25452025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Trial Designs in Amyotrophic Lateral Sclerosis: Does One Design Fit All?
    Nicholson KA; Cudkowicz ME; Berry JD
    Neurotherapeutics; 2015 Apr; 12(2):376-83. PubMed ID: 25700798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALS biomarkers for therapy development: State of the field and future directions.
    Benatar M; Boylan K; Jeromin A; Rutkove SB; Berry J; Atassi N; Bruijn L
    Muscle Nerve; 2016 Feb; 53(2):169-82. PubMed ID: 26574709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS).
    Poppe L; Rué L; Robberecht W; Van Den Bosch L
    Exp Neurol; 2014 Dec; 262 Pt B():138-51. PubMed ID: 25017368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design.
    Fournier CN
    Neurotherapeutics; 2022 Jul; 19(4):1180-1192. PubMed ID: 35819713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proposed BioRepository platform solution for the ALS research community.
    Sherman A; Bowser R; Grasso D; Power B; Milligan C; Jaffa M; Cudkowicz M
    Amyotroph Lateral Scler; 2011 Jan; 12(1):11-6. PubMed ID: 21128868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.